MedPath

Phase 3 study2 of KCI002 in pediatric patients

Phase 3
Recruiting
Conditions
Constipation
Registration Number
JPRN-jRCT2031220631
Lead Sponsor
Yoshimura Yuya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

1. Patients who correspond to Rome IV criteria.
2. Patients whose serum Mg level is within the standard range etc.

Exclusion Criteria

1. Constipation patients based on congenital organic disease
2. Patients with renal impairment.
3. Patients diagnosed with hypermagnesemia etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of Spontaneous Bowel Movement.
Secondary Outcome Measures
NameTimeMethod
1. Percentage of subjects who did not correspond to Rome IV criteria in the last week (1 week) .<br>2. Percentage of patients who had bowel movement within 24 and 48 hours after the first dose and time to first spontaneous bowel movement etc.
© Copyright 2025. All Rights Reserved by MedPath